Congress urged to pass Opioid Workforce Act

Dec 05, 2019 - 03:16 PM
opioids

The Congressional Academic Medicine Caucus and the Association of American Medical Colleges today sponsored a Capitol Hill briefing to highlight the urgent nationwide need for more physicians to treat substance use disorders. In calling for passage of the AHA-supported Opioid Workforce Act (H.R. 3414/S.2892), the briefing featured remarks from Reps. Brad Schneider, D-Ill., and Susan Brooks, R-Ind., the bill’s lead House sponsors, and Rep. Phil Roe (R-TN), a member of the Energy and Commerce Committee. Panelists included Bradley Allen, M.D., of the Indiana University School of Medicine; Scott Teitelbaum, M.D., of the American Society of Addiction Medicine; and Barbara Allen, executive director of James’ Place, a Maryland-based advocacy group that promotes greater access to care. 

Related News Articles

Headline
House adopts Senate-passed budget resolution, marking next step toward narrow reconciliation bill
The House April 29 passed a Senate-approved budget resolution by a 215-211 vote. Now that the House and Senate have passed…
Headline
President names Nicole Saphier as new surgeon general nominee
President Trump April 30 announced that Nicole Saphier, M.D., has been nominated to be the next U.S. surgeon general. Saphier is a radiologist and…
Headline
Lawmakers urged by AHA to support key health initiatives in FY 2027 appropriations bill 
The AHA April 29 urged House and Senate appropriations committee leaders to fund health care programs that have been successful in improving access to care for…
Headline
AHA urges Congress to advance policies that lower costs without reducing access 
The AHA submitted a statement for the record to the House Ways and Means Committee for its April 28 hearing with health system CEOs.In the statement, the AHA…
Chairperson's File
Chair File: Leadership Dialogue — The Role of Advocacy in Advancing Health Care with AHA Executive Vice President Stacey Hughes
Public
We’re at a watershed moment in health care, which gives us opportunities to strengthen how we serve patients and communities. Health care leaders must help…
Headline
FDA fast-tracks the development of psychedelic medications following president’s executive order
The Food and Drug Administration today announced it is accelerating regulatory action on a new class of psychedelic-based therapies, following an April 18…